Kuvan Powder, For Solution
FDA Label NDC 68135-482

34 label sections · Submitted to the FDA by Biomarin Pharmaceutical Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Biomarin Pharmaceutical Inc. for the product Kuvan (NDC 68135-482). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1  indications and usage, 2.1 recommendations prior to kuvan treatment, 2.2 recommended dosage and administration, other, 3  dosage forms and strengths, 4  contraindications, 5.1 hypersensitivity reactions including anaphylaxis, 5.2 upper gastrointestinal mucosal inflammation, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Evaluation Period

Existing dietary protein and Phe intake should not be modified during the evaluation period.

If a 10 mg/kg per day starting dose is used, then response to therapy is determined by change in blood Phe following treatment with KUVAN at 10 mg/kg per day for a period of up to 1 month. Blood Phe levels should be checked after 1 week of KUVAN treatment and periodically for up to a month. If blood Phe does not decrease from baseline at 10 mg/kg per day, the dose may be increased to 20 mg/kg per day. Patients whose blood Phe does not decrease after 1 month of treatment at 20 mg/kg per day do not show a biochemical response and treatment with KUVAN should be discontinued in these patients.

If a 20 mg/kg per day starting dose is used, then response to therapy is determined by change in blood Phe following treatment with KUVAN at 20 mg/kg per day for a period of 1 month. Blood Phe levels should be checked after 1 week of KUVAN treatment and periodically during the first month. Treatment should be discontinued in patients who do not show a biochemical response (blood Phe does not decrease) after 1 month of treatment at 20 mg/kg per day [see Warnings and Precautions (5.4)].

Dosage Adjustment

Once responsiveness to KUVAN has been established, the dosage may be adjusted within the range of 5 to 20 mg/kg per day according to biochemical response to therapy (blood Phe). Periodic blood Phe monitoring is recommended to assess blood Phe control, especially in pediatric patients [see Warnings and Precautions (5.3)].

KUVAN Tablets

  • KUVAN tablets may be swallowed either as whole tablets or dissolved in 120 to 240 mL of water or apple juice and taken orally within 15 minutes of dissolution.
  • It may take a few minutes for the tablets to dissolve.
  • To make the tablets dissolve faster, tablets may be stirred or crushed.
  • The tablets may not dissolve completely. Patients may see small pieces floating on top of the water or apple juice. This is normal and safe for patients to swallow.
  • If after drinking the medicine, patients still see pieces of the tablet in the container, more water or apple juice can be added to make sure all of the medicine is consumed.
  • KUVAN tablets may also be crushed and then mixed in a small amount of soft foods such as apple sauce or pudding.
  • KUVAN Powder for Oral Solution

    Patients weighing greater than 10 kg

    • KUVAN powder for oral solution should be dissolved in 120 to 240 mL of water or apple juice and taken orally within 30 minutes of dissolution.
    • KUVAN powder for oral solution may also be stirred in a small amount of soft food such as apple sauce or pudding.
    • Empty the contents of the packet(s) in water, apple juice, or a small amount of soft foods and mix thoroughly. The powder should dissolve completely.
    • Patients weighing 10 kg or less (use 100 mg packets)

      • For infants weighing 10 kg or less, KUVAN powder for oral solution can be dissolved in as little as 5 mL of water or apple juice and a portion of this solution corresponding to a 10 mg/kg dose may be administered orally via an oral dosing syringe.
      • Table 1 provides dosing information for infants at the recommended starting dose of 10 mg/kg per day.
      • Refer to Table 2 for dosing information at 20 mg/kg per day if dosage adjustment is needed.
      • Table 1: 10 mg/kg per day Dosing Table for Infants Weighing 10 kg or Less

        Patient

        Weight (kg)

        Starting Dose: 10 mg/kg per day*

        Dose (mg)

        KUVAN Powder for Oral Solution 

         100 mg Packets Dissolved†

        Dilution Volume
        (mL)‡

        Administered Dose volume

        (mL)§

          1

        10

        1

        10

         1

          2

        20

        1

        10

         2

          3

        30

        1

        10

         3

          4

        40

        1

        10

         4

          5

        50

        1

        10

         5

          6

        60

        1

        5

         3

          7

        70

        1

        5

          3.5

          8

        80

        1

        5

         4

          9

        90

        1

        5

        4.5

        10

        100

        1

        5

        5

        *Starting dose for infants is 10 mg/kg per day. Dosing information for 20 mg/kg per day is provided in Table 2.

        †Powder for oral solution provided in single use packets containing 100 mg KUVAN per packet.

        ‡Volume of water or apple juice to dissolve KUVAN Powder for Oral Solution.

        §Discard remainder of mixture after volume to be administered is drawn.

         

        Table 2: 20 mg/kg per day Dosing Table for Infants Weighing 10 kg or Less

        Patient

        Weight (kg)

        20 mg/kg per day

        Dose (mg)

        KUVAN Powder for Oral Solution 

         100 mg Packets* Dissolved

        Dilution Volume
        (mL)†

        Administered
        Dose volume

        (mL)§

          1

          20

        1

        5

          1

          2

          40

        1

        5

          2

          3

          60

        1

        5

          3

          4

          80

        1

        5

          4

          5

        100

        1

        5

          5

          6

        120

        2

        5

          3

          7

        140

        2

        5

          3.5

          8

        160

        2

        5

          4

          9

        180

        2

        5

          4.5

        10

        200

        2

        5

        5

        *Powder for oral solution provided in single use packets containing 100 mg KUVAN per packet.

        †Volume of water or apple juice to dissolve KUVAN Powder for Oral Solution.

        §Discard remainder of mixture after volume to be administered is drawn.

* Please review the disclaimer below.